(Questions) ALBA synchrotron capabilities for biomedical studies 25 de xuño de 2018
(Questions) ALBA synchrotron capabilities for biomedical studies
First day focused on the advances related to the diagnosis of diseases.
second day focused on therapies for cancer, neurological or neurodegenerative diseases.
The Symposium brings together more than 200 researchers from Europe and the United States (121 women and 87 men) and comprises a total of 20 papers, ten guest speakers or ten other new researchers, as well as 45 scientific poster sessions.